ACE + ARB works best according to this...
Boston, MA - A new study shows a significant reduction in the incidence of Alzheimer's disease and dementia among subjects taking angiotensin-receptor blockers (ARBs), compared with those taking ACE inhibitors or other cardiovascular drugs [1].
Further, there appeared to be a reduction in rates of disease progression, indicated by the time to admission to a nursing home or death, among those taking ARBs, the authors note.
"We also saw that the people who did the best appeared to be those who were taking ARBs together with ACE inhibitors," said senior author Dr Benjamin Wolozin (Boston University School of Medicine, MA).
"There, the data actually get very striking; we saw a 55% lower incidence of Alzheimer's [disease] or dementia, and a 70% decrease in nursing-home admissions," Wolozin added.
Their report was published online January 12, 2010 in BMJ.
www.theheart.org/article/1043019.do
News 
Market Data 
Discover 
